Scholar Rock Holding Corp
SRRK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001727196
In the last 90 days, Scholar Rock Holding Corp insiders filed 1 open-market purchase and 0 sales; 308 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $5.69B
- Insider buysLast 90 days, $12.0M in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +36 vs. previous quarter
- 308
- 13F valueReported value at the end of Q2 2026
- $7.63B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $0
- No comparable prior period
- Net income, FY2025
- -$377.9M
- No comparable prior period
- Free cash flow, FY2025
- -$300.6M
- No comparable prior period
- Revenue, Q3 FY2026
- $570.0K
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 23.5M
- Shares sold short
- Change
- +1.30M
- +5.9% vs. previous
- Days to cover
- 13.58
- At average daily volume
Superinvestors holding SRRK, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding SRRK at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Scholar Rock Holding Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 (view filing)7:47 PM ET | Oct 23-26 | 4 days | Akkaraju SrinivasDirector | PPurchase | +289.5K | $41.45 | +$12.0M | +66.8%723.0K after | 6 lots |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Flier Jeffrey S.Director | SSale | −3.05K | $53.88 | −$164.5K | −9.9%27.9K after | 3 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Gilman MichaelDirector | SSale | −2.54K | $53.87 | −$137.1K | −4.1%59.5K after | 3 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Burow KristinaDirector | SSale | −3.05K | $53.74 | −$164.1K | −2.6%114.7K after | 2 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Reed JoshuaDirector | SSale | −3.05K | $53.74 | −$164.1K | −13.5%19.5K after | 2 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Peng KatieDirector | SSale | −5.45K | $53.88 | −$293.4K | −13.7%34.3K after | 3 lots10b5-1 |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Woods KeithChief Operating Officer | SSale | −10.2K | $49.57 | −$506.6K | −1.6%620.1K after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Vaishnaw AkshayPresident of R&D | SSale | −12.2K | $49.57 | −$607.0K | −1.9%630.5K after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Sinha VikasChief Financial Officer | SSale | −10.4K | $49.57 | −$516.0K | −1.7%619.9K after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Hallal DavidChief Executive Officer | SSale | −30.6K | $49.57 | −$1.52M | −1.8%1.64M after |
Top 10 13F holders, Q2 2026
See all 308 holdersThe largest institutional positions in Scholar Rock Holding Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 17,995,241 | $989.7M | 0.04% | +752,089+4.4% | Added |
| Siren, L.L.C. | 9,575,013 | $526.6M | 10.69% | −1,250,000−11.5% | Reduced |
| BlackRock, Inc. | 9,494,084 | $522.2M | 0.01% | +2,024,791+27.1% | Added |
| Samsara BioCapital, LLC | 6,897,652 | $379.4M | 31.16% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 6,794,837 | $373.7M | 0.04% | +588,219+9.5% | Added |
| Wellington Management Group LLP | 6,727,085 | $370.0M | 0.06% | +9,430+0.1% | Added |
| Orbis Allan Gray Ltd | 5,933,533 | $326.3M | 1.12% | +1,753,550+42.0% | Added |
| Vanguard Capital Management LLC | 4,767,880 | $262.2M | 0.01% | +876,533+22.5% | Added |
| State Street Corp | 4,728,681 | $260.1M | 0.01% | +697,364+17.3% | Added |
| Redmile Group, LLC | 4,311,092 | $237.1M | 15.92% | −4,755,529−52.5% | Reduced |
Holders of 5% or more of SRRK
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Scholar Rock Holding Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%14.1M shares | – | Feb 8, 20216 filings | Feb 12, 2025 | SEC |
| Invus Global Management, LLC | 13G/A | 8.00%9.58M shares | −3.40 ppfrom 11.40% | Jul 29, 20243 filings | Aug 13, 2026 | SEC |
| Samsara BioCapital, L.P. | 13D/A | 7.20%6.99M shares | – | Feb 14, 20234 filings | Oct 7, 2025 | SEC |
| Wellington Management Group LLP | 13G | 5.60%5.76M shares | New | Feb 10, 20261 filing | Feb 10, 2026 | SEC |
| Price T Rowe Associates Inc | 13G/A | 5.40%6.21M shares | −1.80 ppfrom 7.20% | Feb 16, 20218 filings | May 15, 2026 | SEC |